ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Human umbilical-cord-derived mesenchymal stem cells in combination with rapamycin reduce cartilage degradation via inhibition of the AKT/mTOR signaling pathway

Bie, Yanan; Chen, Qianqing; Xu, Jiahuan; Ou, Baofang; Chen, Boyu; Guan, Yajin; Xie, Shuilin*广东药学院; 南方医科大学
Immunopharmacology and Immunotoxicology2023-9-3DOI: 10.1080/08923973.2023.2189062
2阅读
引用收藏
分享

摘要

Background and aimsMesenchymal stem cell (MSC) therapy is a promising strategy for treating osteoarthritis (OA). However, the inflammatory microenvironment, apoptosis of transplanted cells, and shear forces during direct injection limit the therapeutic efficacy. This study aimed to explore the role of rapamycin combined with human umbilical-cord-derived mesenchymal stem cells (hUMSCs) in OA rabbits in vivo.MethodsOA rabbits received an intra-articular injection of a collagenase solution. Gross observations, X-ray examinations, and histological examinations were performed to detect cartilage degradation levels. The fluorescent membrane dye DiR was used to label hUMSCs. In the combination therapy group, rapamycin was injected into the rabbit knee joint one day post the intra-articular injection of hUMSCs. Bioinformatics and transcriptome profiling of the knee meniscus were used to evaluate the potential molecular mechanisms of the combination therapy.ResultsOur study shows that rapamycin combined with hUMSCs significantly ameliorated OA severity in vivo, enhancing matrix synthesis and promoting cartilage repair. The combination therapy was more efficient than rapamycin or hUMSC treatment alone. Moreover, bioinformatics and transcriptomic analyses revealed that combination therapy might enhance autophagy in chondrocytes, partially by inhibiting the mTOR pathway.ConclusionsOur study indicates that the combination therapy of rapamycin and hUMSCs may promote cartilage repair in OA rabbits through the mTOR pathway and offers a novel approach for OA therapy.The translational potential of this articleOur study provides new evidence to support the use of hUMSCs in combination with rapamycin as a potential candidate for OA treatment.

学科与关键词

关键词
Human umbilical-cord-derived mesenchymal stem cellsosteoarthritisrapamycincombination therapymTOR signaling pathway
相关
加载中…
  • Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy
    Ma, Jian-Chao; Luo, Tingting; Feng, Binyang; Huang, Zicheng; Zhang, Yiqing; Huang, Hanqing; Yang, Xiao; Wen, Jing; Bai, Xiaochun*; Cui, Zhong-Kai*JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21(1): 361.
  • Effect of bone marrow mesenchymal stem cell transplantation combined with lugua polypeptide injection on osteoarthritis in rabbit knee joint
    Huang, Huajun; Zhang, Ping; Xiang, Chunling; Zeng, Canjun; Du, Qingjun*; Huang, Wenhua*Connective Tissue Research, 2022, 63(4): 370-381.被引 6
  • Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells
    Lu, Yao*; Chen, Jieli; Li, Lihua; Cao, Yumei; Zhao, Yang; Nie, Xiaoyu; Ding, Changhai*JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20(1): 89.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Immunopharmacology and Immunotoxicology
发表日期
2023-09-03
卷期
第 45 卷, 第 5 期
页码
549-557
DOI
10.1080/08923973.2023.2189062
语言
ENGLISH
成果收录
SCIE

作者

  • B

    Bie, Yanan (第一作者)

    guangdong pharmaceut univ

  • C

    Chen, Qianqing

    southern med univ

查看全部 7 位作者收起作者
  • X

    Xu, Jiahuan

    southern med univ

  • O

    Ou, Baofang

    southern med univ

  • C

    Chen, Boyu

    southern med univ

  • G

    Guan, Yajin

  • X

    Xie, Shuilin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417